Chronic Airway Disease, Mucus Rheology and Exacerbations
Status:
Not yet recruiting
Trial end date:
2023-05-15
Target enrollment:
Participant gender:
Summary
The main objective of this trial is to compare the exacerbation rates over 12 months of
follow-up between a group of patients with COPD treated according to standardized management
(standardized comparator arm: azithromycin prescribed in case of severe sputum according to
the CASA-Q score) and a similar group in which azithromycin is prescribed according to mucus
rheology (experimental arm).